Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment.
Authors:
- W J McKennaWMW J McKenna
- L HarrisLHL Harris
- G PerezGPG Perez
- D M KriklerDKD M Krikler
- C OakleyCOC Oakley
- J F GoodwinJGJ F Goodwin
Open Access
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.Heart, 1980
- M mode echocardiography in hypertrophic cardiomyopathy: Diagnostic criteria and prediction of obstructionThe American Journal of Cardiology, 1980
- Arrhythmia in hypertrophic cardiomyopathy: Exercise and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapyThe American Journal of Cardiology, 1980
- Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status.Circulation, 1979
- Treatment of hypertrophic obstructive cardiomyopathy with verapamil.Heart, 1979
- Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy.Circulation, 1979
- “Malignant” hypertrophic cardiomyopathy: Identification of a subgroup of families with unusually frequent premature deathThe American Journal of Cardiology, 1978
- Sudden death in patients with hypertrophic cardiomyopathy: Characterization of 26 patients without functional limitationThe American Journal of Cardiology, 1978
- PROGNOSIS AND MORTALITY OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHYThe Lancet, 1973
- Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment.Heart, 1973